Current Edition

aged 18-60

CureVac scraps its first COVID-19 vaccine and pivots to a second

After months sticking with its coronavirus vaccine, CureVac has finally given up. CureVac executives had long argued the shot could still play a role in …

Continue Reading →
coronavirus vaccine

CureVac scales back mRNA manufacturing for coronavirus vaccine

While not acknowledged directly, the “corresponding changes in demand” could also stem from disappointing clinical trial results CureVac released for its vaccine in mid-June, which …

Continue Reading →